FDA releases new draft social media guidance

Share this article:
FDA released two guidance documents today for manufacturers and their representatives to communicate online about prescription drugs and medical devices.

The first draft guidance focused on recommendations for risk/benefit information on services with character space limitations, like Twitter and paid search on Google or Yahoo.

The second guidance discussed how to correct third-party information related to their own prescription drugs and medical devices, and stated that all misinformation should be addressed in a visible and defined portion of a forum on the internet or social media—regardless of whether it's positive or negative.

An in-depth analysis will follow tomorrow.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.